twoXAR is a pharmaceutical company with the vision to become the global leader in drug discovery and development by creating new medicines with the potential to benefit one billion patients. The company has built a development portfolio targeting more than 18 different diseases. twoXAR’s unique approach to drug discovery combines steps from the traditional multi-step approach to R&D that severely limits the pace of drug discovery. This novel method – coupled with the company’s proprietary AI-driven platform – enables twoXAR to select a disease and initiate in vivo testing in months, instead of years.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
18 disease areas in fibrotic, immunology, oncology, and other
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):